Saturday April 9, 2011

Fresenius Medical Care
Magnesium – Beneficial Effects Over & Above Phosphate Binding

Date: Saturday April 9, 2011
Time: 12:00 PM – 1:15 PM
Room: West Ballroom A (Vancouver Convention Center)

Causes, Consequences & Management of Hyperphosphataemia
Ziad Massy (France)

Clinical View on Beneficial Effects of Magnesium in Health and Disease
Wajeh Qunibi (USA)

Calcium Magnesium based phosphate Binders: A New Approach in Hyperphosphataemia
Adrian Covic (Romania)

Danone Research
Nutrition, Fluids & Kidneys: Public Health Issues

Date: Saturday April 9, 2011
Time: 12:00 PM – 1:15 PM
Room: West Ballroom B (Vancouver Convention Center)

Chair: Dr Ewa Nowak, PhD. (France)

Water and Kidney Physiology
Prof Ivan Tack, M. D., PhD. (France)

Diet, Environment (Fluid & Nutrition) and Kidney Diseases
Prof. Richard J. Johnson, M. D.,  (USA)

Kidney Stones, Environmental and Economical Issues Around the World
Prof. William G. Robertson, PhD DSc (UK)

Novartis Pharma
Direct Renin Inhibition: Optimizing Treatment Strategies for Patients with Co-morbid Hypertension, Diabetes and Nephropathy

Date: Saturday April 9, 2011
Time: 12:00 PM – 1:15 PM
Room: West Ballroom C (Vancouver Convention Center)

Chair: Ernesto Schiffrin (Canada)

The Ongoing Burden of Co-morbid Hypertension, Diabetes and Nephropathy: The Need for New Treatment Strategies
Thomas Unger (Germany)

Direct Renin Inhibition: An Opportunity for Improved Management of Patients with Hypertension and Diabetes?
Matthew Weir (USA)

The Potential for Cardio-renal Protection with Direct Renin Inhibition: What Does the Future Hold?
Hans-Henrik Parving (Denmark)

Genzyme
The Evolving Clinical Framework of CKD-MBD: Managing the Mineral and Endocrine Disruptions Across All Stages of CKD

Date: Saturday April 9, 2011
Time: 12:00 PM – 1:15 PM
Room: West Ballroom D (Vancouver Convention Center)

Disordered Phosphorus in CKD-MBD
David A. Bushinsky (USA)

Applying Evidence to the Management of Mineral Disorders in Chronic Kidney Disease
Geoffrey Block (USA)

Management of CKD-MBD in Advanced Chronic Kidney Disease: Results from The Dialysis Outcomes and Practice Patterns Study (DOPPS)
Francesca Tentori (USA)

Sunday April 10, 2011

Amgen
Vascular Calcification in Dialysis Patients: Do We Care Enough?

Date: Sunday April 10, 2011
Time: 12:00 PM – 1:15 PM
Room: West Ballroom A (Vancouver Convention Center)

Chair: Steven Soroka (Canada)

Mechanisms of Vascular Calcification
Gerard London (France)

Assessment of VC: Why, When & How?
Geoffrey Block (USA)

Primary and Secondary Prevention of VC: The Evidence
David Goldsmith (UK)

Gambro
Therapy Options for Individualized Quality-Assured Dialysis 

Date: Sunday April 10, 2011
Time: 12:00 PM – 1:15 PM
Room: West Ballroom B (Vancouver Convention Center)

Chairman: Robert M. Lindsay

Managing Both Quality and Cost with a Growing Dialysis Population
Ingrid Ledebo (Sweden)

Does the Choice of Dialyzer Matter?
Mercedeh Kiaii (Canada)

Achieving Tolerable Fluid Removal to Dry Weight
Jennifer MacRae (Canada)

DOPPS
International Variations in Hemodialysis Care and Outcomes: The Dialysis Outcomes and Practice Patterns Study (DOPPS)

Date: Sunday April 10, 2011
Time: 12:00 PM – 1:15 PM
Room: West Ballroom C (Vancouver Convention Center)

Initiated in 1996, the Dialysis Outcomes and Practice Patterns Study (DOPPS) is a prospective cohort study of hemodialysis patients and practices, studying representative samples of dialysis units and patients in 12 countries. An overarching goal of the DOPPS is to identify modifiable practices associated with longer life and better quality of life for dialysis patients. The objective of this symposium is to provide the audience with an update of recent important DOPPS findings. Results related to diversity of provider survey data, variation in dialysate composition, and management of hepatitis C infection will be presented. All presentations will have a practical clinical focus. A question period (up to 3 minutes) will follow each presentation, and a panel discussion will end the symposium.

Chairs – Dr. Bruce Robinson and Dr. Nathan Levin

DOPPS Overview: A Platform for Collaboration and New International Opportunities
Bruce Robinson, MD - Ann Arbor, MI (USA)       
            
International Diversity of Provider Opinions: Associations with Clinical Targets and Outcomes
David Mendelssohn, MD - Toronto, ON (Canada)    

Optimal Dialysate Composition: A Readily Modifiable Means to Improve Outcomes
Hugh Rayner, MD – Birmingham (UK)

Hepatitis C Infection among Hemodialysis Patients: Common, Deadly, yet Untreated
David Goodkin, MD – Bellevue, WA (USA)

Panel Discussion

Monday April 11, 2011

Abbott International
Clinical Advances at the Heart of the Cardio-Renal Syndrome

Date: Monday April 11, 2011
Time: 12:00 PM – 1:15 PM
Room: West Ballroom A (Vancouver Convention Center)

Chair: Paul René de Cotret

Understanding VDR Activation and the Heart
Bruce Hendry (UK)

The Importance of Albuminuria as a Risk Factor in Cardiovascular Diseases
Hiddo Lambers Heerspink (The Netherlands)

VDR Activation and Mineral Metabolism – The IMPACT-SHPT Study
Samina Khan (USA)

Merck
New Advances in Cardiovascular Risk Reduction in Patients with Chronic Kidney Disease

Date: Monday April 11, 2011
Time: 12:00 PM – 13:15 PM
Room: West Ballroom C (Vancouver Convention Center)

Chairperson: Marcello Tonelli (Canada)

Overview of Epidemiology of CKD
Marcello Tonelli (Canada)

Vascular Disease in CKD
William Keane (USA)

Presentation of SHARP Study Results
Oxford University SHARP Collaborative Group

Questions & Answers
Panel

ISN
Nephrology – A Global Cause that Needs You

Date: Monday April 11, 2011
Time: 12:00 PM – 1:15 PM
Room: West Ballroom D (Vancouver Convention Center)

Introduction to Global Outreach (GO)
Bill Couser (USA)

Sister Renal Centers
Paul Harden (UK)

Fellowships
David Harris (Australia)

Research & Prevention
Giuseppe Remuzzi (Italy)

Young Nephrologists
Fiona Brown (Australia)

Disaster Relief
Ray Vanholder (Belgium)

What else does ISN Offer
John Feehally (UK)